DRUG COST;
DRUG EFFICACY;
FOLLOW UP;
HEALTH CARE QUALITY;
HUMAN;
MALARIA;
MALARIA CONTROL;
MORTALITY;
NOTE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PREVENTIVE HEALTH SERVICE;
PRIORITY JOURNAL;
VACCINATION;
WORLD HEALTH ORGANIZATION;
ECONOMICS;
MALARIA, FALCIPARUM;
PUBLIC HEALTH;
THEORETICAL MODEL;
HUMANS;
MALARIA VACCINES;
MALARIA, FALCIPARUM;
MODELS, THEORETICAL;
PUBLIC HEALTH;
From the circumsporozoite protein to the RTS,S/AS candidate vaccine
J Cohen, V Nuessenzweig, R Nussenzweig, J Vekemans, A Leach From the circumsporozoite protein to the RTS,S/AS candidate vaccine Hum Vaccin 6 2010 90 96
Efficacy and safety of the RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial
RTS,S Clinical Trials Partnership Efficacy and safety of the RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial Lancet 386 2015 31 45
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine candidate: A systematic comparison of predictions from four mathematical models
published online Nov 5
MA Penny, R Veity, CA Bever et al. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine candidate: a systematic comparison of predictions from four mathematical models Lancet 2015 published online Nov 5. http://dx.doi.org/10.1016/S0140-6736(15)00725-4
A marked reduction in mortality among participants in a clinical trial that removed barriers to care and implemented national case management guidelines
New Orleans, LA; Nov 2-6
Hamel MJ, Oneko M, Williamson J, et al. A marked reduction in mortality among participants in a clinical trial that removed barriers to care and implemented national case management guidelines. 63rd Annual Meeting of the American Society of Tropical Medicine and Hygiene; New Orleans, LA; Nov 2-6, 2014. 631 (abstr).
A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc)
AL Wilson IPTc Taskforce A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc) PLoS One 6 2011 e16976
European Medicines Agency (EMA) First malaria vaccine receives positive scientific opinion from EMA http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2015/07/news-detail-002376.jsp&mid=WC0b01ac058004d5c1 July 24, 2015 (Oct 30, 2015).
WHO Pilot implementation of first malaria vaccine recommended by WHO advisory groups http://www.who.int/mediacentre/news/releases/2015/sage/en/ Oct 23, 2015 (accessed Oct 30, 2015).
